Management of and counseling for psychotropic drug-induced sexual dysfunction

Pharmacotherapy

Volumn 19, Issue 7, 1999, Pages 823-831

  Gutierrez, Mary A ^a,c   Stimmel, Glen L ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMANTADINE; AMFEBUTAMONE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CITALOPRAM; CLOMIPRAMINE; CYPROHEPTADINE; DEXAMPHETAMINE; FLUOXETINE; GINKGO BILOBA EXTRACT; LITHIUM; MIRTAZAPINE; NEFAZODONE; NEUROLEPTIC AGENT; NEUROTRANSMITTER; PAROXETINE; PHENELZINE; PHENYLEPHRINE; PHENYTOIN; PRAZOSIN; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SILDENAFIL; TRAZODONE; UNINDEXED DRUG; VALPROIC ACID; YOHIMBINE;

ANORGASMIA; ARTICLE; CLINICAL TRIAL; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; INSOMNIA; INTRACAVERNOUS DRUG ADMINISTRATION; LIBIDO; PATIENT COUNSELING; PREMATURE EJACULATION; PRIAPISM; SEXUAL AROUSAL; SEXUAL DYSFUNCTION;

COUNSELING; HUMANS; IMPOTENCE; PSYCHOTROPIC DRUGS;

EID: 0032834444     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.19.10.823.31553     Document Type: Article

References (57)

1. Schiavi RC, Segraves RT. The biology of sexual function. Psychiatr Clin N Am 1995;18:7-23.
2. Crenshaw TL, Goldberg JP. Sexual pharmacology: drugs that affect sexual function. New York: WW Norton & Co., 1996.
3. Stahl SM. Nitric oxide physiology and pharmacology. J Clin Psychiatry 1998;59:101-102.
4. Stahl SM. Psychopharmacology of antidepressants. London: Martin Dunitz Press, 1997.
5. Rosen RC, Leiblum SR. Treatment of sexual disorders in the 1990s: an integrated approach. J Consulting Clin Psychology 1995;63:877-90.
6. Singer C, Weiner WJ. Sexual dysfunction: a neuro-medical approach. Armonk, NY: Futura Publishing Co., Inc., 1994.
7. Gitlin MJ. Psychotropic medications and their effects on sexual function: diagnosis, biology, and treatment approaches. J Clin Psychiatry 1994;55:406-13.
8. Vidal-Moreno JF, Moreno Pardo B, Jimenez Cruz JF. Assessment of tobacco impact on penile vascularization with echo-Doppler and intracavernous injection. Actas Urologicas Espanola 1996;20:363-71.
9. Sullivan G, Lukoff D. Sexual side effects of antipsychotic medication: evaluation and interventions. Hosp Commun Psychiatry 1990;41:1238-41.
10. Lee HS, Kim CH, Song DH, et al. Clozapine does not elevate serum prolactin levels in healthy men. Biol Psychiatry 1995;38:762-4.
11. Misra LK, Erpenbach JE, Hamlyn H, Fuller WC. Quetiapine: a new atypical antipsychotic. SD J Med 1998;51:189-93.
12. Crawford AM, Beasley CM Jr, Tollefson GD. The acute and longterm effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrations. Schizophr Res 1997;26:41-54.
13. Popli A, Gupta S, Rangwani SR. Risperidone-induced galactorrhea associated with a prolactin elevation. Ann Clin Psychiatry 1998;10:31-3.
14. Montejo-Gonzalez AL, Izquierdo JA, Dedesma A, et al. SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. J Sex Marital Ther 1997;23:176-94.
15. Montero WO, Noshirvani HF, Marks IM, et al. Anorgasmia from clomipramine in obsessive-compulsive disorder: a controlled trial. Br J Psychiatry 1987;151:107-12.
16. DeVeaugh-Geiss J, Landau P, Katz R. Preliminary results from a multicenter trial of clomipramine in obsessive-compulsive disorder. Psychopharmacol Bull 1989;25:36-40.
17. Segraves RT. Antidepressant-induced sexual dysfunction. J Clin Psychiatry 1998;59(suppl 4):48-54.
18. Feiger A, Keiv A, Shrivastava RK, et al. Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction. J Clin Psychiatry 1996;57(suppl 2):53-62.
19. Stimmel GL, Dopheide JA, Stahl SM. Mirtazapine: an antidepressant with noradrenergic and specific serotonergic effects. Pharmacotherapy 1997;17:10-21.
20. Ashton AK, Rosen RC. Accommodation to serotonin reuptake inhibitor-induced sexual dysfunction. J Sex Marital Ther 1998;24:191-2.
21. Assalian P, Margolese HC. Treatment of antidepressant-induced sexual side effects. J Sex Marital Ther 1996;22:218-24.
22. Stimmel GL. How to counsel patients about depression and its treatment. Pharmacotherapy 1995;15(pt 2):100S-4.
23. Rothschild AJ. Selective serotonin reuptake inhibitor-induced sexual dysfunction: efficacy of a drug holiday. Am J Psychiatry 1995;152:1514-16.
24. Balon R. Drug holidays to counter sexual dysfunction [letter]. Am J Psychiatry 1996;153:1370-1.
25. Zajecka J, Tracy KA, Mitchell S. Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review. J Clin Psychiatry 1997;58:291-7.
26. Walker PW, Cole JO, Gardner EA, et al. Improvement in fluoxetine-associated sexual dysfunction in patients switched to bupropion. J Clin Psychiatry 1993;54:459-65.
27. Hollander E, McCarley A. Yohimbine treatment of sexual side effects induced by serotonin reuptake blockers. J Clin Psychiatry 1992;53:207-9.
28. Shrivastava RK, Shrivastava S, Overweg N, Schmitt M. Amantadine in the treatment of sexual dysfunction associated with selective serotonin reuptake inhibitors [letter]. J Clin Psychopharmacol 1995;15:83-4.
29. Cohen AJ, Bartlik B. Ginkgo biloba for antidepressant-induced sexual dysfunction. J Sex Marital Ther 1998;24:139-43.
30. Nurnberg HG, Lauriello J, Hensley PL, et al. Sildenafil for iatrogenic serotonergic antidepressant medication-induced sexual dysfunction in 4 patients. J Clin Psychiatry 1999;60:33-5.
31. Ashton AK, Rosen RC. Bupropion as an antidote for serotonin reuptake inhibitor-induced sexual dysfunction. J Clin Psychiatry 1998;59:112-15.
32. Reynolds RD. Sertraline-induced anorgasmia treated with intermittent nefazodone [letter]. J Clin Psychiatry 1997;58:89.
33. Althof SE. Pharmacologic treatment of rapid ejaculation. Psychiatr Clin North Am 1995;18:85-94.
34. Balon R. Antidepressants in the treatment of premature ejaculation. J Sex Marital Ther 1996;22:85-96.
35. Althof SE, Levine SB, Corty EW, et al. A double-blind crossover trial of clomipramine for rapid ejaculation in 15 couples. J Clin Psychiatry 1995;56:402-7.
36. Ludovico GM, Corvasce A, Pagliarulo G, et al. Paroxetine in the treatment of premature ejaculation. Br J Urol 1996;77:881-2.
37. Waldinger MD, Hengeveld MW, Zwinderman AH. Paroxetine treatment of premature ejaculation: a double-blind, randomized, placebo-controlled study. Am J Psychiatry 1994;151:1377-9.
38. Mendels J, Camera A, Sikes C. Sertraline treatment for premature ejaculation J Clin Psychopharmacol 1995;15:341-6.
39. Lee HS, Song DH, Kim CH, Choi HK. An open clinical trial of fluoxetine in the treatment of premature ejaculation. J Clin Psychopharmacol 1996;16:379-82.
40. Kindler S, Dolberg OT, Cohen H, et al. The treatment of comorbid premature ejaculation and panic disorder with fluoxetine. Clin Neuropharmacol 1997;20:466-71.
41. Banos JE, Bosch F, Farre M. Drug-induced priapism: its aetiology, incidence, and treatment. Med Toxicol 1989;4:46-58.
42. Patel AG, Mukherji K, Lee A. Priapism associated with psychotropic drugs. Br J Hosp Med 1996;55:315-19.
43. Tekell JL, Smith EA, Silva JA. Prolonged erection associated with risperidone treatment. Am J Psychiatry 1995;152:1097.
44. Ahmad S. Paroxetine-induced priapism. Arch Intern Med 1995;155:645.
45. Levenson JL. Priapism associated with bupropion treatment. Am J Psychiatry 1995;152:813.
46. Berk M, Acton M. Citalopram-associated clitoral priapism: a case series. Int Clin Psychopharmacol 1997;12:121-2.
47. Gartrell N. Increased libido in women receiving trazodone. Am J Psychiatry 1986;143:781-2.
48. Pescatori ES, Engleman JC, Davis G, et al. Priapism of the clitoris: a case report following trazodone use. J Urol 1993;149:1557-9.
49. 1-adrenergic blocking drugs. Drug Saf 1994;11:12-20.
50. Pecknold JC, Langer SF. Priapism: trazodone versus nefazodone. J Clin Psychiatry 1996;57:547-8.
51. Lee M, Cannon B, Sharifi R. Chart for preparation of dilutions of α-adrenergic agonists for intracavemous use in treatment of priapism. J Urol 1995;153:1182-3.
52. Muruve N, Hosking DH. Intracorporeal phenylephrine in the treatment of priapism. J Urol 1996;155:141-3.
53. Dittrich A, Altrecht K, Bar-Moshe O, Vandendris M. Treatment of pharmacological priapism with phenylephrine. J Urol 1991;146;323-4.
54. Ghadirian AM, Annable L, Belanger MC. Lithium, benzodiazepines, and sexual function in bipolar patients. Am J Psychiatry 1992;149:801-5.
55. Isojarvi JIT, Pakarinen AJ, Ylipalosaari PJ, Myllyla W. Serum hormones in male epileptic patients receiving anticonvulsant medication. Arch Neurol 1990;47:670-6.
56. Franceschi M, Perego L, Cavagnini F, et al. Effects of long-term antiepileptic therapy on the hypothalamic-pituitary axis in man. Epilepsia 1984;25:46-52.
57. Lydiard RB, Howell EF, Laraia MT, Ballenger JC. Sexual side effects of alprazolam [letter]. Am J Psychiatry 1987;144:254-5.